Glimirace MP 1mg/500mg/15mg Tablet
Marketer
Hemera Life Sciences Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimirace MP 1mg/500mg/15mg Tablet
Metformin/Glimepiride/Pioglitazone 1mg/500mg/15mg tablets offer triple-action blood sugar management. This combined medication, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, thus reducing blood glucose. Dosage and duration should strictly follow your physician's instructions. Take with food to prevent digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals raises hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, increased bone fracture risk, and respiratory infections. Prior to commencing treatment, inform your doctor of any kidney, liver, or heart conditions. Pregnant or lactating individuals require medical consultation before use. Kidney function tests are standard pre-treatment checks. Limit alcohol consumption as it may intensify side effects.
Primary Ingredients of Glimirace MP 1mg/500mg/15mg Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Glimirace MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimirace MP 1mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimirace MP 1mg/500mg/15mg tablet whole; do not damage it by chewing, crushing, or splitting. Administer this medication with food.
Common Side effects of Glimirace MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimirace MP 1mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Glimirace MP 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
How Glimirace MP 1mg/500mg/15mg Tablet works:
Glimirace MP 1mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimirace MP 1mg/500mg/15mg tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimirace MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimirace MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimirace MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimirace MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimirace MP 1mg/500mg/15mg Tablet :
Should you forget to take a Glimirace MP 1mg/500mg/15mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimirace MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently